News

Akari Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Video webcast now available on-demandBOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...
PharmaTimes2d
Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy
Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in ...
BioWorld3d
Akari Therapeutics working to advance lead asset, find other targets
Akari Therapeutics plc announced that it is continuing key research on its antibody-drug conjugate (ADC) payload PH1 to ...
JTC Team Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference Now Live
Video webcasts from participating companies now available here FRENCHTOWN, NJ / ACCESS Newswire / July 22, 2025 / JTC Team ...
The Manila Times4d
Kaida BioPharma Participates in the Virtual Investor "What’s Your Story” Summer Spotlight On-Demand Conference
FORT LAUDERDALE, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma ("Kaida” or the "Company”), an early-stage pharma ...
The Manila Times3d
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
pharmaphorum3d
Update: Rumour confirmed as Lilly buys Verve Therapeutics
Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics ...